Literature DB >> 6802881

Characterisation of Liver membrane autoantibodies determined by indirect immunofluorescence.

U Tage-Jensen, H Permin, K Krogsgaard.   

Abstract

Indirect immunofluorescence studies were performed using sera and IgG-Fab2 fragments from patients with chronic active hepatitis (CAH) who were positive for a liver membrane antibody (LMA). The specificity was investigated using hepatocytes from humans as well as rabbit, rat, guinea pig and monkey. Only sera also positive for smooth muscle antibody gave staining of lymphocytes and absorption with F-actin from rabbit muscle abolished this as well as all other smooth muscle staining without influencing LMA. It was concluded that LMA, routinely detected by indirect immunofluorescence using rabbit hepatocytes, represents specific binding to non-species-specific membrane antigens which are normal constituents of human hepatocytes. The antigen is separately located, and not cross-reactive with F-actin.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802881      PMCID: PMC497537          DOI: 10.1136/jcp.35.3.315

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  12 in total

1.  Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis.

Authors:  U Hopf; K H Meyer zum Büschenfelde; W Arnold
Journal:  N Engl J Med       Date:  1976-03-11       Impact factor: 91.245

2.  High resolution two-dimensional electrophoresis of proteins.

Authors:  P H O'Farrell
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

3.  Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis.

Authors:  K Lidman; G Biberfeld; A Fagraeus; R Norberg; R Torstensson; G Utter; L Carlsson; J Luca; U Lindberg
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

4.  Immunofluorescent tracing of smooth muscle contractile protein antigens in tissues other than smooth muscle.

Authors:  P Trenchev; P Sneyd; E J Holborow
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

5.  Circulating autoantibodies in patients with acute viral hepatitis. Relation to etiology and clinical course.

Authors:  U Tage-Jensen; H Permin; F Hardt; E Juhl; L R Mathiesen; J O Nielsen; L Ranek
Journal:  Scand J Gastroenterol       Date:  1980       Impact factor: 2.423

6.  Liver specific antigens. Purification and characterization.

Authors:  P A Miescher
Journal:  Clin Exp Immunol       Date:  1972-01       Impact factor: 4.330

7.  Auto-antibodies in Sjögren's syndrome. With special reference to liver-cell membrane antibody (LMA).

Authors:  R Manthorpe; H Permin; U Tage-Jensen
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

8.  LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?

Authors:  K H Meyer zum Büschenfelde; M Manns; T H Hütteroth; U Hopf; W Arnold
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

9.  Autoantibodies, histocompatibility antigens and testosterone in males with alcoholic liver cirrhosis.

Authors:  C Gluud; U Tage-Jensen; M Bahnsen; O Dietrichson; A Svejgaard
Journal:  Clin Exp Immunol       Date:  1981-04       Impact factor: 4.330

10.  Liver-cell-membrane autoantibody specific for inflammatory liver diseases.

Authors:  U Tage-Jensen; W Arnold; O Dietrichson; F Hardt; U Hopf; K H Meyer Zum Büschenfelde; J O Nielsen
Journal:  Br Med J       Date:  1977-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.